A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function

Clinical trial NCT06858696 · COMPLETED

Trial details

NCT number: NCT06858696
Sponsor: X4 Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency

Start date: 2025-02-28
Primary completion: 2026-01-12
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.